Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1977 2
1980 1
1981 3
1982 1
1983 3
1985 2
1986 1
1987 1
1989 1
1998 2
1999 3
2000 2
2001 1
2002 3
2003 4
2004 2
2005 3
2006 4
2007 5
2008 4
2009 4
2010 6
2011 8
2012 8
2013 12
2014 14
2015 19
2016 21
2017 18
2018 19
2019 23
2020 25
2021 25
2022 25
2023 24
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

261 results

Results by year

Filters applied: . Clear all
Page 1
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05).
Motoi F, Kosuge T, Ueno H, Yamaue H, Satoi S, Sho M, Honda G, Matsumoto I, Wada K, Furuse J, Matsuyama Y, Unno M; Study Group of Preoperative Therapy for Pancreatic Cancer (Prep) and Japanese Study Group of Adjuvant Therapy for Pancreatic cancer (JSAP). Motoi F, et al. Among authors: satoi s. Jpn J Clin Oncol. 2019 Feb 1;49(2):190-194. doi: 10.1093/jjco/hyy190. Jpn J Clin Oncol. 2019. PMID: 30608598 Clinical Trial.
New criteria of resectability for pancreatic cancer: A position paper by the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS).
Oba A, Del Chiaro M, Satoi S, Kim SW, Takahashi H, Yu J, Hioki M, Tanaka M, Kato Y, Ariake K, Wu YHA, Inoue Y, Takahashi Y, Hackert T, Wolfgang CL, Besselink MG, Schulick RD, Nagakawa Y, Isaji S, Tsuchida A, Endo I. Oba A, et al. Among authors: satoi s. J Hepatobiliary Pancreat Sci. 2022 Jul;29(7):725-731. doi: 10.1002/jhbp.1049. Epub 2021 Oct 20. J Hepatobiliary Pancreat Sci. 2022. PMID: 34581016
Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A position paper by experts in pancreatic surgery at the Joint Meeting of the International Association of Pancreatology (IAP) & the Japan Pancreas Society (JPS) 2022 in Kyoto.
Hashimoto D, Satoi S, Fujii T, Sho M, He J, Hackert T, Del Chiaro M, Jang JY, Gulla A, Yoon YS, Shan YS, Lou W, Valente R, Furuse J, Oba A, Nagai M, Terai T, Tanaka H, Sakai A, Yamamoto T, Yamaki S, Matsumoto I, Murakami Y, Takaori K, Takeyama Y. Hashimoto D, et al. Among authors: satoi s. Pancreatology. 2023 Sep;23(6):682-688. doi: 10.1016/j.pan.2023.07.005. Epub 2023 Jul 20. Pancreatology. 2023. PMID: 37507301 Review.
Perioperative interventions to reduce pancreatic fistula following pancreatoduodenectomy: meta-analysis.
PARANOIA Study Group:; Writing group:; Halle-Smith JM, Pande R, Hall L, Hodson J, Roberts KJ; Steering committee:; Arshad A, Connor S, Conlon KCP, Dickson EJ, Giovinazzo F, Harrison E, de Liguori Carino N, Hore T, Knight SR, Loveday B, Magill L, Mirza D, Mitta A, Pandanaboyana S, Perry RJ, Pinkney T, Samra J, Siriwardena AK, Satoi S, Skipworth J, Stättner S, Sutcliffe RP, Tingstedt B, Roberts KJ. PARANOIA Study Group:, et al. Among authors: satoi s. Br J Surg. 2022 Aug 16;109(9):812-821. doi: 10.1093/bjs/znac074. Br J Surg. 2022. PMID: 35727956
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society.
Tomimaru Y, Eguchi H, Shimomura Y, Kitamura T, Inoue Y, Nagakawa Y, Ohba A, Onoe S, Unno M, Hashimoto D, Kawakatsu S, Hayashi T, Higuchi R, Kitagawa H, Uemura K, Kimura Y, Satoi S, Takeyama Y; Committee of Clinical Research, Japan Pancreas Society. Tomimaru Y, et al. Among authors: satoi s. J Gastroenterol. 2023 Aug;58(8):790-799. doi: 10.1007/s00535-023-01988-7. Epub 2023 Jun 17. J Gastroenterol. 2023. PMID: 37329351 Free PMC article.
Randomized phase II trial of chemoradiotherapy with S-1 versus combination chemotherapy with gemcitabine and S-1 as neoadjuvant treatment for resectable pancreatic cancer (JASPAC 04).
Sugiura T, Toyama H, Fukutomi A, Asakura H, Takeda Y, Yamamoto K, Hirano S, Satoi S, Matsumoto I, Takahashi S, Morinaga S, Yoshida M, Sakuma Y, Iwamoto H, Shimizu Y, Uesaka K. Sugiura T, et al. Among authors: satoi s. J Hepatobiliary Pancreat Sci. 2023 Nov;30(11):1249-1260. doi: 10.1002/jhbp.1353. Epub 2023 Sep 25. J Hepatobiliary Pancreat Sci. 2023. PMID: 37746781 Clinical Trial.
261 results